Milestone Pharmaceuticals Statistics
Total Valuation
MIST has a market cap or net worth of $87.70 million. The enterprise value is $74.53 million.
| Market Cap | 87.70M |
| Enterprise Value | 74.53M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MIST has 53.15 million shares outstanding. The number of shares has increased by 1.19% in one year.
| Shares Outstanding | 53.15M |
| Shares Change (YoY) | +1.19% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | 0.63% |
| Owned by Institutions (%) | 33.96% |
| Float | 33.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 88.76 |
| Forward PS | n/a |
| PB Ratio | 5.29 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 74.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.11, with a Debt / Equity ratio of 3.09.
| Current Ratio | 10.11 |
| Quick Ratio | 9.58 |
| Debt / Equity | 3.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22.37 |
Financial Efficiency
Return on equity (ROE) is -171.00% and return on invested capital (ROIC) is -89.13%.
| Return on Equity (ROE) | -171.00% |
| Return on Assets (ROA) | -64.40% |
| Return on Capital (ROIC) | -89.13% |
| Revenue Per Employee | $21,277 |
| Profits Per Employee | -$1.27M |
| Employee Count | 47 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.43% in the last 52 weeks. The beta is 1.77, so MIST's price volatility has been higher than the market average.
| Beta (1Y) | 1.77 |
| 52-Week Price Change | -56.43% |
| 50-Day Moving Average | 1.67 |
| 200-Day Moving Average | 2.39 |
| Relative Strength Index (RSI) | 47.42 |
| Average Volume (30 Days) | 323,553 |
Short Selling Information
The latest short interest is 559,535, so 1.05% of the outstanding shares have been sold short.
| Short Interest | 559,535 |
| Short Previous Month | 480,129 |
| Short % of Shares Out | 1.05% |
| Short % of Float | 1.65% |
| Short Ratio (days to cover) | 1.11 |
Income Statement
In the last 12 months, MIST had revenue of $1.00 million and -$59.69 million in losses. Loss per share was -$1.39.
| Revenue | 1.00M |
| Gross Profit | 1.00M |
| Operating Income | -61.10M |
| Pretax Income | -59.69M |
| Net Income | -59.69M |
| EBITDA | -57.04M |
| EBIT | -57.13M |
| Loss Per Share | -$1.39 |
Balance Sheet
The company has $66.00 million in cash and $51.78 million in debt, giving a net cash position of $14.23 million or $0.27 per share.
| Cash & Cash Equivalents | 66.00M |
| Total Debt | 51.78M |
| Net Cash | 14.23M |
| Net Cash Per Share | $0.27 |
| Equity / Book Value | 16.77M |
| Book Value Per Share | 0.32 |
| Working Capital | 65.81M |
Cash Flow
In the last 12 months, operating cash flow was -$46.42 million and capital expenditures -$112,000, giving a free cash flow of -$46.54 million.
| Operating Cash Flow | -46.42M |
| Capital Expenditures | -112,000 |
| Free Cash Flow | -46.54M |
| FCF Per Share | -$1.08 |
Margins
Gross margin is 100.00%, with operating and profit margins of -6,109.80% and -5,968.50%.
| Gross Margin | 100.00% |
| Operating Margin | -6,109.80% |
| Pretax Margin | -5,968.50% |
| Profit Margin | -5,968.50% |
| EBITDA Margin | -5,703.90% |
| EBIT Margin | -5,713.10% |
| FCF Margin | -4,653.60% |
Dividends & Yields
MIST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.19% |
| Shareholder Yield | -1.19% |
| Earnings Yield | -67.24% |
| FCF Yield | -52.43% |
Analyst Forecast
The average price target for MIST is $11.33, which is 576.01% higher than the current price. The consensus rating is "Buy".
| Price Target | $11.33 |
| Price Target Difference | 576.01% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 220.84% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MIST has an Altman Z-Score of -6.6 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.6 |
| Piotroski F-Score | 1 |